MarketFoolery

The Crocs turnaround isn’t turning around just yet. Valeant Pharmaceuticals gets a visit from the SEC. Plus, we’re heading to Austin, Texas for SXSW!

Direct download: Market_Foolery_03_01_2016.mp3
Category:podcast -- posted at: 2:53pm EDT

1